| Financial Year |
March 31 2023 |
| Monetary Funds |
20,626,389,828.20 |
| Held-for-trading Financial Assets |
760,195,381.19 |
| Notes Receivable |
2,755,734,836.37 |
| Accounts Receivable |
14,335,256,448.88 |
| Advances to Suppliers |
6,587,053,846.90 |
| Other Receivables |
1,193,982,476.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
49,912,942.61 |
| Inventories |
15,004,634,794.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,128,115,405.11 |
| Total Current Assets |
75,785,350,120.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,164,423,825.17 |
| Investment Properties |
75,216,664.02 |
| Fixed Assetes |
58,227,506,412.43 |
| Under-construction Projects |
16,878,567,333.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,667,716,490.68 |
| R&D expenses |
-- |
| Goodwill |
129,641,093.62 |
| Long-Term Deferred and Prepaid Expenses |
990,715,986.77 |
| Deferred Income Tax Assets |
1,620,882,381.59 |
| Other Non-Current Assets |
9,333,063,799.30 |
| Sub-Total of Non-Current Assets |
104,216,165,292.95 |
| Total Assets |
180,001,515,413.59 |
| Short-Term Loans |
1,652,012,155.39 |
| Trading Financial liabilities |
32,801,540.99 |
| Notes Payable |
16,059,845,629.03 |
| Accounts Payable |
23,064,934,969.44 |
| Accounts Received In Advance |
247,263.34 |
| Employee Compensation Payable |
1,305,133,467.22 |
| Taxes Payable |
1,243,533,159.71 |
| Interest Payable |
-- |
| Dividend Payable |
143,688,104.08 |
| Other payables |
2,484,394,773.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,221,343,643.19 |
| Other Current Liabilities |
1,262,967,488.61 |
| Sub-Total of Current Liabilities |
59,350,657,245.11 |
| Long-term Loans |
26,076,441,329.03 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,885,402,149.46 |
| Special Payable |
-- |
| Estimatied Liabilities |
343,057,066.40 |
| Deferred Income Tax Liabilities |
983,783,262.99 |
| Other Non-Current Liabilities |
1,571,315.93 |
| Sub-Total of Non-Current Liabilities |
34,145,849,247.65 |
| Total Liabilities |
93,496,506,492.76 |
| Paid-In Capital(Or Share Stock) |
3,888,503,789.00 |
| Capital Surplus |
12,017,989,831.49 |
| Surplus Reserve |
1,932,958,796.20 |
| LESS:Treasury Stock |
457,333,534.20 |
| Undistributed Profits |
38,950,120,660.65 |
| Minority Stockholder's Interest |
24,671,894,929.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
61,833,113,990.92 |
| Owner's Equity（Stockholder's Equity） |
86,505,008,920.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
180,001,515,413.59 |
